Skip to main content
SpringerLink
Log in

New Developments in the Etiology, Diagnosis, Treatment and Prevention of Infectious Complications in Patients with Leukemia

  • Chapter
Chronic and Acute Leukemias in Adults

Part of the book series: Cancer Treatment and Research ((CTAR,volume 26))

Abstract

The last several years have witnessed significant improvements in the remission rate and survival of adults with leukemia. Infection, however, remains a major problem for these patients, particularly when they are granulocytopenic. During the last decade, considerable strides in supportive care have helped to reduce infection-related morbidity and mortality. The principles employed are unique to the compromised host and require a departure from those considered standard in general infectious disease. An appreciation of the approach to the diagnosis, management and prevention of infection in the patient with acute leukemia is essential for the clinical oncologist and infectious disease specialist. In this chapter we will focus on the emerging body of data which has defined the boundaries and principles of management. In so doing, we will highlight the new developments in the patterns of infection and the agents available to treat them. Our goal is to place current data and controversies in focus and perspective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bodey GP, Rodriguez V, Chang HY, Harboni G: Fever and infection in leukemia patients. A study of 494 consecutive patients. Cancer 41:1610–1622, 1978.

    PubMed  CAS  Google Scholar 

  2. Bodey GP, Bolivar R, Fainstein V: Infectious complications in leukemia patients. Semin Hematol 19:193–226, 1982.

    PubMed  CAS  Google Scholar 

  3. EORTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137:14–29, 1978.

    Google Scholar 

  4. Love LJ, Schimpff SC, Schiffer CA, Wiernik PH: Improved prognosis for granulocytopenic patients with gram-negative bacteremia. Am J Med 68:643–648, 1980.

    PubMed  CAS  Google Scholar 

  5. Pizzo PA, Ladish S, Simon RM, Gill F, Levine AS: Increasing incidence of gram-positive sepsis in cancer patients. Med Pediatr Oncol 5:241–244, 1978.

    PubMed  CAS  Google Scholar 

  6. Kilton LJ, Fossieck BE, Cohen MH, et al.: Bacteremia due to gram-positive cocci in patients with neoplastic disease. Am J Med 66:596–602, 1979.

    PubMed  CAS  Google Scholar 

  7. Wade JC, Schimpff SC, Newman KA. Wiernik PH: Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 97:503–508, 1982.

    PubMed  CAS  Google Scholar 

  8. Lowder JN, Lazarus HM, Herzig RH: Bacteremias and fungemias in oncologic patients with central cenous catheters. Changing spectrum of infection. Arch Intern Med 142:1456–1459, 1982.

    PubMed  CAS  Google Scholar 

  9. Winston DJ, Dudnick DV, Chapin M, et al.: Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med 143:32–36, 1983.

    PubMed  CAS  Google Scholar 

  10. Myers JP, Linneman CC Jr: Bacteremia due to methicillin-resistant Staphylococcus aureus. J Infect Dis 145:532–536, 1982.

    PubMed  CAS  Google Scholar 

  11. Haley RW, Hightower AW, Khabbaz RF, et al.: The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Ann Intern Med 97:297–308, 1982.

    PubMed  CAS  Google Scholar 

  12. Acar JF, Courvalin P, Chabbert YA: Methicillin-resistant staphylococcemia: bacteriologic failure of treatment with cephalosporins. Antimicrob Ag Chemother 10:280–285, 1970.

    CAS  Google Scholar 

  13. Sorrell TC, Packman DR, Shanker S, Foldes M, Munro R: Vancomycin therapy for methi-cillin resistant Staphylococcus aureus. Ann Intern Med 97:344–350, 1982.

    PubMed  CAS  Google Scholar 

  14. Friedman LE, Brown AE, Quesada O, Armstrong D: Significant S. epidermidis infections in children with leukemia and lymphoma. 22nd Interscien Confern Antimicrob Ag Chemother: 232, 1982.

    Google Scholar 

  15. Lu C, Bishop C, Braine H, Ownsend T, Saral R: Staphyloccus epidermidis sepsis in cancer patients. Proc Am Soc Clin Oncol 2:96, 1983.

    Google Scholar 

  16. Joshi J, Newman K, Tenny J, et al.: Staphylococcus epidermidis pneumonia in granulocytopenic patients with acute leukemia. Proc Am Soc Clin Oncol 2:90, 1983.

    Google Scholar 

  17. Pizzo PA, Ladisch S, Witebsky FG: Alpha-hemolytic streptocci: clinical significance in the cancer patient. Med Pediatr Oncol 4:367–370, 1978.

    PubMed  CAS  Google Scholar 

  18. Hande KR, Witebsky FG, Brown MS, et al.: Sepsis with a new species of Corynebacterium. Ann Intern Med 85:423–426, 1976.

    PubMed  CAS  Google Scholar 

  19. Young VM, Meyers WF, Moody MR, Schimpff SC: The emergence of coryneform bacteria as a cause of nosocomial infections in compromised hosts. Am J Med 70:646–650, 1981.

    PubMed  CAS  Google Scholar 

  20. Riley PS, Hollis DG, Utter GB, Weaver RE, Baker CN: Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens. J Clin Microbiol 9:418–424, 1979.

    PubMed  CAS  Google Scholar 

  21. Gill VJ, Manning C, Lamson M, et al.: Antibiotic-resistant group JK bacteria in hospitals. J Clin Microbiol 13:472–477, 1981.

    PubMed  CAS  Google Scholar 

  22. Stamm WE, Tompkins LS, Wagner KF, et al.: Infection due to corynebacterium species in marrow transplant patients. Ann Intern Med 91:167–173, 1979.

    PubMed  CAS  Google Scholar 

  23. Pizzo PA, Robichaud KJ, Gill FA, et al.: Duration of empiric antibiotic therapy in grnulocytopenic patients with cancer. Am J Med 67:194–200, 1979.

    PubMed  CAS  Google Scholar 

  24. Van der Waaij: The colonization resistance of the digestive tract in man and animals. In: Clinical and Experimental Gnotobiotics. Fleidner T, Hest H, Niethammer P, Pflieger H (eds). Zentrablatt fur bacteriologie, Supp 7, Gustav Fischer Verlag 1979, p 155.

    Google Scholar 

  25. Degregorio MW, Lee WM, Linker CA, et al.: Fungal infections in patients with acute leukemia. Am J Med 73:543–548, 1982.

    PubMed  CAS  Google Scholar 

  26. Meyer RD, Young LS, Armstrong D, Yu B: Aspergillosis complicating neoplastic disease. Am J Med 54:6–15, 1973.

    PubMed  CAS  Google Scholar 

  27. Sickles EA, Young VM, Greene WH, Wiernik PH: Pneumonia in acute leukemia. Ann Intern Med 79:528–534, 1973.

    PubMed  CAS  Google Scholar 

  28. Goldstein E, Hoeprick PD: Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis 125:190–193, 1972.

    Google Scholar 

  29. Edwards JE, Lehrer RI, Stiehm ER, Fischer TJ, Young LS: Severe candidal infections. Ann Intern Med 89:91–106, 1978.

    PubMed  Google Scholar 

  30. Schimpff SC: Surveillance cultures. J Infect Dis 144:81–84, 1981.

    PubMed  CAS  Google Scholar 

  31. Kramer BS, Pizzo PA, Robichaud KJ, et al.: The role of serial microbiologic survaillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. Am J Med 72:561–568, 1982.

    PubMed  CAS  Google Scholar 

  32. Aisner J, Murillo J, Schimpff SC, et al.: Invasive aspergillosis in acute leukemia: Correlation with nose cultures and antibiotic use. Ann Intern Med 90:4–9, 1979.

    PubMed  CAS  Google Scholar 

  33. Sandford GR, Merz WG, Wingard JR, et al.: The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 142:503–509, 1980.

    PubMed  CAS  Google Scholar 

  34. Pizzo PA, Robichaud KJ, Gill FA, et al.: Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 72:101–110, 1982.

    PubMed  CAS  Google Scholar 

  35. Wingard JR, Merz WG, Saral R: Candida tropicalis: a major pathogen in immunocompromised hosts. Ann Intern Med 91:539–543, 1979.

    PubMed  CAS  Google Scholar 

  36. Henry NK, McLimans CA, Wright AJ, et al.: Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol 17:864–869, 1983.

    PubMed  CAS  Google Scholar 

  37. Callen PW, Filly RA, Marcus FS: Ultrasonography and computed tomography in the evaluation of hepatic microabscesses in the immunocompromised patient. Radiology 136:433–434, 1980.

    PubMed  CAS  Google Scholar 

  38. Bartley DL, Hughes WT, Parvey LS, Parham D: Computed tomography of hepatic and splenic fungal abscesses in leukemic children. Ped Infect Dis 1:317–321, 1982.

    CAS  Google Scholar 

  39. Beutler SM, Young LS, Lindquist LB. et al.: Delayed complications of candidemia. 22nd Interscien Confern Antimicrob Ag Chemother: 154, 1982.

    Google Scholar 

  40. Dick JD, Merz WG, Saral R: Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Ag Chemother 18:158–163, 1980.

    CAS  Google Scholar 

  41. Seidenfeld SM, Cooper BH, Smith JW, et al.: Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. J Infect Dis 147:116–119, 1983.

    PubMed  CAS  Google Scholar 

  42. Gluckman SJ, Ries K, Abrutyn E: Allescheria (Petriellidium) boydii sinusitis in a compromised host. J Clin Microbiol 5:481–484, 1977.

    PubMed  CAS  Google Scholar 

  43. Torres-Rojas JR, Stratton CW, Sanders CV, et al.: Candidal suppurative peripheral thrombophlebitis. Ann Intern Med 96:431–435, 1982.

    PubMed  CAS  Google Scholar 

  44. Aisner J, Schimpff SC, Bennett JE, et al..: Aspergillus infections in cancer patients. Association with fireproofing material in a new hospital. JAMA 235:411–412, 1976.

    PubMed  CAS  Google Scholar 

  45. Romett JL, Newan RK: Aspergillosis of the nose and paranasal sinuses. Laryngoscope 92:764–766, 1982.

    PubMed  CAS  Google Scholar 

  46. Beal MF, O’Carroll CP, Kleinman GM, Grossman RI: Aspergillosis of the nervous system. Neurology 32:473–479, 1982.

    PubMed  CAS  Google Scholar 

  47. Pennington JE: Aspergillus pneumonia in hematologic malignancy. Arch Intern Med 137:769–771, 1977.

    PubMed  CAS  Google Scholar 

  48. Lehrer TI, Howard DH, Sypherd PS, et al.: Mucormycosis. Ann Intern Med 93:93–108, 1980.

    Google Scholar 

  49. Aisner J, Schimpff SC, Sutherland JC, et al..: Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization. Am J Med 61:23–28, 1976.

    PubMed  CAS  Google Scholar 

  50. Acuna G, Winston D, Young L: Ketoconazole prophylaxis of fungal infection in the gra-culocytopenic patient: a double blind, randomized, controlled trial. 21st Interscien Confern Antimicrob Ag Chemother 852, 1981.

    Google Scholar 

  51. Haupt HM, Merz WG, Beschorner WE, et al.: Colonization and infection with Trichos-poron species in the immunocompromised host. J Infect Dis 147:199–203, 1983.

    PubMed  CAS  Google Scholar 

  52. Kauffman CA, Israel KS, Smith JW: Histoplasmosis in immunosuppressed patients. Am J Med 64:923–932, 1978.

    PubMed  CAS  Google Scholar 

  53. Onal E, Lopata M, Lourenco RV: Disseminated pulmonary blastomycosis in an immunosuppressed patient. Am Rev Respir Dis 113:83–86, 1976.

    PubMed  CAS  Google Scholar 

  54. Kaplan MH, Armstrong D, Rosen P: Tuberculosis complicating neoplastic disease. Cancer 33:850–858, 1974.

    PubMed  CAS  Google Scholar 

  55. Feld R, Bodey GP, Groschel D: Mycobacteriosis in patients with malignant disease. Arch Intern Med 136:67–70, 1976.

    PubMed  CAS  Google Scholar 

  56. Greene JB, Sidhu GS, Lewin S, et al.: Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosecuals and drug abusers. Ann Intern Med 97:539–545, 1982.

    PubMed  CAS  Google Scholar 

  57. Golomb HM, Hanaver SB: Infectious complications associated with hairy cell leukemia. J Infect Dis 143:639–643, 1981.

    PubMed  CAS  Google Scholar 

  58. Ortbals DW, Marr JJ: A comparative study of tuberculosis and other mycobacterial infections and their association with malignancy. Am Rev Respir Dis 117:39–45, 1978.

    PubMed  CAS  Google Scholar 

  59. Palmer DL, Harvey RL, Wheeler JK: Diagnostic and therapeutic consideration in Nocar-dia asteroides infection. Medicine 53:391–401, 1974.

    PubMed  CAS  Google Scholar 

  60. Young LS, Armstrong D, Blevins A, Lieberman P: Nocardia asteroides infection complicating neoplastic disease. Am J Med 50:356–367, 1971.

    PubMed  CAS  Google Scholar 

  61. Present CA, Wiernik PH, Serpick AA: Factors affecting survival in nocardiosis. Am Rev Resp Dis 108:1444–1448, 1973.

    Google Scholar 

  62. Cox F, Hughes WT: Contagious and other aspects of nocardiosis in the compromised host. Pediatrics 55:135–138, 1975.

    PubMed  CAS  Google Scholar 

  63. Feldman S, Cox F: Viral infections and haematological malignancies. Clin Haematol 5:311–328, 1976.

    PubMed  CAS  Google Scholar 

  64. Hamilton JR, Overall JC, Glasgow LA: Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun 14:982–989, 1976.

    PubMed  CAS  Google Scholar 

  65. Rand KH, Pollard RB, Merigan TC: Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 298:951–953, 1978.

    PubMed  CAS  Google Scholar 

  66. Hersman J, Meyers JD, Thomas ED, et al.: The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 96:149–152, 1982.

    PubMed  CAS  Google Scholar 

  67. Neimann PE, Reeves W, Ray G, et al.: A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis 136:754–767, 1977.

    Google Scholar 

  68. Winston DJ, Gale RP, Meyer DV, Young LS, UCLA Bone Marrow Transplantation Group: Infectious complications of human bone marrow transplantation. Medicine 58:1–31, 1979.

    PubMed  CAS  Google Scholar 

  69. Meyers JD, Flournoy N, Thomas ED: Nonbacterial pneumonia after allogeneic marrow transplantation-review of 10 years’ experience. Rev Infect Dis 4:1119–1132, 1982.

    PubMed  CAS  Google Scholar 

  70. Meyers JD, McGuffin RW, Bryson YJ, et al.: Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 146:80–84, 1982.

    PubMed  CAS  Google Scholar 

  71. Wade JC, Hintz M, McGuffin RW, et al.: Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med 73(1A):249–256, 1982.

    PubMed  CAS  Google Scholar 

  72. Meyers JD, McGuffin RW, Neiman PE, et al.: Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. J Infect Dis 141:555–562, 1980.

    PubMed  CAS  Google Scholar 

  73. Winston DJ, Pollard RB, Ho WG, et al.: Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med 97:11–18, 1982.

    PubMed  CAS  Google Scholar 

  74. Meyers JD, Leszczynski J, Zaia JA, et al.: Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 98:442–446, 1983.

    PubMed  CAS  Google Scholar 

  75. Lam MT, Pazin GJ, Armstrong JA, Ho M: Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: a prospective study. Cancer 48:2169–2171, 1981.

    Google Scholar 

  76. Buss DH, Scharyj M: Herpesvirus infection of the esophagus and other visceral organs in adults. Incidence and clinical significance. Am J Med 66:457–462, 1979.

    PubMed  CAS  Google Scholar 

  77. Ch’ien LT, Cannon NJ, Charamella LJ, et al.: Effect of adenine arabinoside on severe herpesvirus hominis infections in man. J Infect Dis 128:658–663, 1973.

    PubMed  Google Scholar 

  78. Wade JC, Newton B, McLaren C, et al.: Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med 96:265–269, 1982.

    PubMed  CAS  Google Scholar 

  79. Meyers JD, Wade JC, Mitchell CD, et al.: Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 73(1A) 229–235, 1982.

    PubMed  CAS  Google Scholar 

  80. Saral R, Burns WH, Laskin OL, et al.: Acyclovir prophylaxis of herpes-simplex-virus infections: a randomized, double-blind controlled trial in bone marrow-transplant recipients. N Engl J Med 305:63–67, 1981.

    PubMed  CAS  Google Scholar 

  81. Pizzo PA, Robichaud KJ, Wesley R, Commers JR: Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 61:153–165, 1982.

    PubMed  CAS  Google Scholar 

  82. Forgacs P: The gallium scan and inflammatory lesions. Arch Intern Med 142:231, 1982.

    PubMed  CAS  Google Scholar 

  83. Ebright JR, Soin JS, Manoli RS: The gallium scan. Problems and misuse in examination of patients with suspected infection. Arch Intern Med 142:246–254, 1982.

    PubMed  CAS  Google Scholar 

  84. Seabold JE, Votaw ML, Keyes JW Jr, et al.: Gallium citrate Ga67 scanning-clinical usefulness in lymphoma patients. Arch Intern Med 136:1370–1374, 1976.

    PubMed  CAS  Google Scholar 

  85. Beightol RW, Baker WJ: Labeling autologous leukocytes with Indium-111 Oxine. Am J Hosp Pharm 37:847–850, 1980.

    PubMed  CAS  Google Scholar 

  86. McDougall IR: The use of white blood cell scanning techniques in infectious disease. In: Current Clinical Topics in infectious Diseases (vol 4), Remington JS, Swartz MN (eds), New York, McGraw Hill CO, pp 130–152, 1983.

    Google Scholar 

  87. Zakhireh B, Thakur ML, Malech HL, et al.: Indium-111 labeled human polymorphonuclear leukocytes. Viability, random migration, chemotaxis, bactericidal capacity, and ultrastructure. J Nucl Med 20:741–747, 1979.

    PubMed  CAS  Google Scholar 

  88. Anstall HB, Coleman RE: Donor-leukocyte imaging in granulocytopenic patients with suspected abscesses: concise communication. J Nucl Med 23:319–321, 1982.

    PubMed  CAS  Google Scholar 

  89. Dutcher JP, Schiffer CA, Johnston GS: Rapid migration of 111indium-labeled granulocytes to sites of infection. N Engl J Med 304:586–589, 1981.

    PubMed  CAS  Google Scholar 

  90. Alavi JB, Alavi A, Staum MM: Evaluation of infection in neutropenic patients with Indium-111-labeled donor granulocytes. Clin Nucl Med 5:397–400, 1980.

    PubMed  CAS  Google Scholar 

  91. Dutcher JP, Schiffer CA, Johnston GS: Migration of 111In-labeled granulocytes to infection sites. N Engl J Med 304:1547, 1981.

    Google Scholar 

  92. McCullough J, Weiblen BJ, Clay ME, Forstrom L: Effect of leukocyte antibodies on the fate in vivo of Indium-111-labeled granulocytes. Blood 58:164–170, 1981.

    PubMed  CAS  Google Scholar 

  93. Hill HR: Enzyme-linked immunosorbent assay and radioimmunoassay in the serologic diagnosis of infectious diseases. J Infect Dis 147:258–263, 1983.

    PubMed  CAS  Google Scholar 

  94. Gordon MA, Gwinn DD: From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on serodiagnosis of systemic mycosis. J Infect Dis 146:570–574, 1982.

    PubMed  CAS  Google Scholar 

  95. Elin RJ, Robinson RA, Levine AS, Wolff SM: Lack Of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med 293:521–524, 1975.

    PubMed  CAS  Google Scholar 

  96. Preisler HD, Hasenclever HF, Henderson ES: Anti-candida antibodies in patients with acute leukemia. Am J Med 51:352–361, 1971.

    PubMed  CAS  Google Scholar 

  97. Gaines JD, Remington JS: Diagnosis of deep infection with Candida, a study of Candida precipitins. Arch Intern Med 132:699–702, 1973.

    PubMed  CAS  Google Scholar 

  98. Felice G, Yu B, Armstrong D: Immunodiffusion and agglutination tests for Candida in patients with neoplastic disease: inconsistent correlation of tesults with invasive infections. J Infect Dis 135:357, 1977.

    Google Scholar 

  99. Guinan ME, Portas MR, Hill HR: The Candida precipitin test in an immunosuppressed population. Cancer 43:299–302, 1979.

    PubMed  CAS  Google Scholar 

  100. Miller GG, Witwer MW, Braude AI, Davis CE: Rapid identification of Candida albicans septicemia in man by gas-liquid chromatography. J Clin Invest 54:1235–1240, 1974.

    PubMed  CAS  Google Scholar 

  101. Weiner MH, Yount WJ: Mannan antigenemia in the diagnosis of invasive Candida infections. J Clin Invest 58:1045–1053, 1976.

    PubMed  CAS  Google Scholar 

  102. Segal E, Berg RA, Pizzo PA, Bennett JE: Detection of Candida antigen In sera of patients with canndidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Micro 10:116–118, 1979.

    CAS  Google Scholar 

  103. Weiner MH, Coats-Stephen M: Immunodiagnosis of systemic candidiasis: Mannan antigenemia detected by radioimmunoassay in experimental and human infections. J Infect Dis 140:989–993, 1979.

    PubMed  CAS  Google Scholar 

  104. Lew MA, Siber GR, Donahue DM, Maiorca F: Enhanced detection with an enzyme-linked immunosorbent assay of Candida mannan in antibody-containing serum after heat extraction. J Infect Dis 145:45–56, 1982.

    PubMed  CAS  Google Scholar 

  105. Kiehn TE, Bernard EM, Gold JWM, Arstrong D: Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum. Science 206:577–580, 1979.

    PubMed  CAS  Google Scholar 

  106. Gold JWM, Wong B, Bernard EM, Kiehn TE, Armstrong D: Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive candidiasis. J Infect Dis 147:504–513, 1983.

    PubMed  CAS  Google Scholar 

  107. Kerkering TM, Espinel-Ingroff A, Shadomy S: Detection of Candida antigenemia by counter immunoelectrophoresis in patients with invasive candidiasis. J Infect Dis 140:659–664, 1979.

    PubMed  CAS  Google Scholar 

  108. Meunier-Carpentier F, Armstrong D: Candida antigenemia, as detected by passive hemagglutination inhibition, in patients with disseminated candidiasis or Candida colonization. J Clin Micro 13:10–14, 1981.

    CAS  Google Scholar 

  109. Young RC, Bennett JE: Invasive aspergillosis: absence of detectable antibody response. Am Rev Resp Dis 104:710–716, 1971.

    PubMed  CAS  Google Scholar 

  110. Schaefer JC, Yu B, Armstrong D: An aspergillus immunodiffusion test in the early diagnosis of aspergillosis in adult leukemia patients. Am Rev Resp Dis 113:325–329, 1976.

    PubMed  CAS  Google Scholar 

  111. Marier R, Smith W, Jansen M, Andriole T: A solid-phase radioimmunoassay for the measurement of antibody to aspergillus in invasive aspergillosis. J Infect Dis 140:771–779, 1979.

    PubMed  CAS  Google Scholar 

  112. Holmberg K, Berdischewsky M, Young LS: Serologic immunodiagnosis of invasive apser-gillosis. J Infect Dis 141:656–664, 1980.

    PubMed  CAS  Google Scholar 

  113. Gold JWM, Fisher B, Yu B, Chein N, Armstrong D: Diagnosis of invasive aspergillosis by passive hemagglutination assay of antibody. J Infect Dis 140:87–94, 1980.

    Google Scholar 

  114. Mishra SK, Falkenberg S, Masihi KN: Efficacy of enzyme-linked immunosorbent assay in serodiagnosis of aspergillosis. J Clin Micro 17:708–710, 1983.

    CAS  Google Scholar 

  115. Shaffer PJ, Lobayashi GS, Medoff G: Demonstration of antigenemia in patients with invasive aspergillosis by solid phase (protein A-rich Staphylococcus aureus) radioimmunoassay. Am J Med 67:627–630, 1979.

    PubMed  CAS  Google Scholar 

  116. Weiner MH: Antigenemia detected by radioimmunoassay in systemic aspergillosis. Ann Intern Med 92:793–796, 1980.

    PubMed  CAS  Google Scholar 

  117. Andrews CP, Weiner MH: Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and apsergillomas. Am J Med 73:372–380, 1982.

    PubMed  CAS  Google Scholar 

  118. Weiner MH, Talbot GH, Gerson SL, et al.: Diagnosis of invasive aspergillosis: utility of fungal antigen detection in contrlled blinded trials. Clin Res 30:381A, 1982.

    Google Scholar 

  119. Schimpff SC, Young VM, Greene WH, et al.: Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 77:707–714, 1972.

    PubMed  CAS  Google Scholar 

  120. Fainstain V, Rodriquez V, Turk M, et al.: Patterns of oropharyngeal and fecal flora in patients with leukemia. J Infect Dis 144:10–18, 1981.

    Google Scholar 

  121. Beachy EH: Bacterial adherence. Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis 143:325–345, 1981.

    Google Scholar 

  122. Schimpff SC, Green WH, Young VM, et al.: Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis 130:s24-s31, 1974.

    PubMed  Google Scholar 

  123. Klastersky J, Debusscher L, Weerts D, et al.: Use of oral antibiotics in protected environment unit: clinical effectiveness and role in the emergence of antibiotic-resistent strains. Pathol Biol 22:5–12, 1974.

    PubMed  CAS  Google Scholar 

  124. Wright AJ, Wilkowske CJ: The penicillins. Mayo Clin Proc 58:21–32, 1983.

    PubMed  CAS  Google Scholar 

  125. Thompson RL, Wright AJ: Cephalosporin antibiotics. Mayo Clin Proc 58:79–87, 1983.

    PubMed  CAS  Google Scholar 

  126. Pizzo PA: Infectious complications in children with cancer. I. Pathophysiology of the compromised host and initial evaluation and management of the febrile cancer patient. J Pediatr 98:341–354, 1981.

    PubMed  CAS  Google Scholar 

  127. Schimpff SC: Empiric antibiotic therapy. Cancer Treat Rep 62:673–680, 1978.

    PubMed  CAS  Google Scholar 

  128. Young LS: Combination or single drug therapy for gram-negative sepsis. In: Current Clinical Topics in Infectious Diseases, (vol 3), Remington JS, Swartz MV (eds). New York, McGraw-Hill Co, 1982, pp 177–205.

    Google Scholar 

  129. Wade JC, Schimpff SC, Newman KA, et al.: Piperacillin or ticarcillin plus amikacin; a double-blind prospective comparison of empiric antibiotic therapy for febrile-granulocy-topenic cancer patients. Am J Med 71:983–990, 1981.

    PubMed  CAS  Google Scholar 

  130. deJongh CA, Wade JC, Schimpff SC, et al.: Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of mox-alactam plus amikacin and ticarcillin plus amikacin. Am J Med 73:89–96, 1982.

    CAS  Google Scholar 

  131. Barnes RC, Winston DJ, Ho WG, et al.: Comparative efficacy and toxicity of moxalactam-piperacillin versus moxalactam-amikacin in febrile granulocytopenic patients. 22nd Inter-scien Confern Antimicrob Ag Chemother: 66, 1982.

    Google Scholar 

  132. dejongh C, Joshi J, Newman K, et al.: Moxalactam plus piperacillin or amikacin: empiric antibiotic therapy for febrile neutropenic cancer patients. 22nd Interscien Confern Antimicrob Ag Chemother: 223, 1982.

    Google Scholar 

  133. Pickard W, Durack D, Gallis H: Randomized trial of moxalactam versus tobramycin plus ticarcillin in 50 febrile neutropenic patients. 22nd Interscien Confern Antimicrob Ag Chemother: 66, 1982.

    Google Scholar 

  134. Alanis A, Graves S, Weinstein AJ: Moxzlactam or nafcillin and tobramycin for empiric therapy of febrile granulocytopenic patients. 22nd Interscien Confern Antimicrob Ag Chemother: 66, 1982.

    Google Scholar 

  135. Hiemenz J, Cotton D, Gress J, et al.: Keflin, gentamicin, carbenicillin vs. ceftazidime as empiric therapy for febrile-granulocytopenic cancer patients. 23rd Interscien Confern Antimicrob Ag Chemother (in press).

    Google Scholar 

  136. Klastersky J, Schimpff SC, Meunier-Carpentier F, et al.: A cooperative investigation of a rational management of granulocytopenic cancer patients. 22nd Interscien Confern Antimicrob Ag Chemother: 66, 1982.

    Google Scholar 

  137. Joshi J, dejongh C, Newman K, Schimpff S: Discontinuation of antibacterial therapy in persistantly febrile, granulocytopenic patients without a demonstrable infectious etiology. 22nd Interscien Confern Antimicrob Ag Chemother: 233, 1982.

    Google Scholar 

  138. Riella MC, Scribner BH: Five years’ experience with a right atrial catheter for prolonged paranteral nutrition at home. Surg Gynecol Obstet 143:205–205, 1976.

    PubMed  CAS  Google Scholar 

  139. Abrahm J, Mullen JL, Jacobson N, et al.: Continuous central venous access in patients with acute leukemia. Cancer Treat Rep 63:2099–2100, 1979.

    PubMed  CAS  Google Scholar 

  140. Hickman RO, Buckner CD, Clift RA, et al.: A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148:871–875, 1979.

    PubMed  CAS  Google Scholar 

  141. Thomas JH, MacArthur RI, Pierce GE, Hermreck AS: Hickman-Broviac catheters. Indications and results. Am J Surg 140:791–796, 1980.

    PubMed  CAS  Google Scholar 

  142. Chillar RK, Farbstein M, Ellington OB, et al.: Use of right atrial catheter for prolonged IV support in cancer patients. Cancer Treat Rep 64:243–246, 1980.

    PubMed  CAS  Google Scholar 

  143. Sanders JE, Hickman RO, Aker S, et al.: Experience with double lumen right atrial catheters. JPEN 6:95–99, 1982.

    CAS  Google Scholar 

  144. Begala JE, Maher K, Cherry JD: Risk of infection associated with the use of Broviac and Hickman catheters. Am J Infect Control 10:17–23, 1981.

    Google Scholar 

  145. Hiemenz JW, Robichaud KJ, Johnston MR, Pizzo PA: Bacteremias in patients with indwelling silastic catheters. Proc Am Soc Clin Oncol 1:57, 1982.

    Google Scholar 

  146. Abrahm JL, Mullen JL: A prospective study of prolonged central venous access in leukemia. JAMA 248:2868–2873, 1982.

    PubMed  CAS  Google Scholar 

  147. Liepman M, Ensminger W, Niederhuber J, et al.: A novel injection system for intravenous chemotherapy administration. Proc Am Assoc Cancer Res/Am Soc Clin Oncol 22:419, 1981.

    Google Scholar 

  148. Perek D, Commers JR, Poplack DG, Pizzo PA: Infectious complications of intraventricular reservoirs in cancer patients. 22nd Interscien Confern Antimicrob Ag Chemother: 232, 1982.

    Google Scholar 

  149. Pizzo PA, Ladisch S, Robichaud KJ: Treatment of gram-positive septicemie in cancer patients. Cancer 45:206–207, 1980.

    PubMed  CAS  Google Scholar 

  150. Shepherd JP: The management of the oral complications of leukemia. Oral Surg 45:543–548, 1978.

    PubMed  CAS  Google Scholar 

  151. Kurrle E, Bhaduri S, Krieger D, et al.: Risk factors for infections of the oropharynx and respiratory tract in patients with acute leukemia. J Infect Dis 144:128–136, 1981.

    PubMed  CAS  Google Scholar 

  152. Greenberg MS, Cohen SG, McKitrick JC, Cassileth PA: The oral flora as a source of septicemia in patients with acute leukemia. Oral Surg 53:32–36, 1982.

    PubMed  CAS  Google Scholar 

  153. Peterson DE, Overholser CD, Schimpff SC, et al.: Relationship of intensive oral hygiene to systemic complications in acute nonlymphocytic leukemia patients. Clin Res 29:440A, 1981.

    Google Scholar 

  154. Peterson DE, Overholser CD: Increased morbidity associated with oral infection in patients with acute nonlymphocytic leukemia. Oral Surg 51:390–393, 1981.

    PubMed  CAS  Google Scholar 

  155. Overhoser CD, Peterson DE, Williams LT, SchimpffSC: Peridontal infections in patients with acute nonlymphocytic leukemia. Prevelance of acute exacerbations. Arch Intern Med 142:551–554, 1982.

    Google Scholar 

  156. Dreizen S, McCredie KB, Keating MJ: Chemotherapy-induced oral mucositis in adult leukemia. Postgrad Med 69:103–112, 1981.

    PubMed  CAS  Google Scholar 

  157. Kostiala I, Kostiala AAI, Kahanpaa A, Elonen E: Acute fungal stomatitis in patients with hematologic malignancies: quantity and species of fungi. J Infect Dis 146:101, 1982.

    Google Scholar 

  158. Oliff A, Bleyer WA, Poplack DG: Methotrexate induced oral mucositis and salivary methotrexate concentrations. Cancer Chemother Pharmacol 2:225–226, 1979.

    PubMed  CAS  Google Scholar 

  159. Whitley R, Barton N, Collins E, et al.: Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med 73(1A):236–240, 1982.

    PubMed  CAS  Google Scholar 

  160. Eras P, Goldstein MJ, Sherlock P: Candida infection of the gastrointenstinal tract. Medicine 51:367–379, 1972.

    PubMed  CAS  Google Scholar 

  161. Ruxer TJ, Walsh KP, Wang KP, et al.: Esophagitis in acute nonlymphocytic leukemia. Proc Am Soc Clin Oncol 2:90, 1983.

    Google Scholar 

  162. Brayko CM, Kozarek RA, Sanowski RA, Lanard BJ: Type 1 herpes simplex esophagitis with concomitant esophageal moniliasis. J Clin Gastroenterol 4:351–355, 1982.

    PubMed  CAS  Google Scholar 

  163. Medoff G, Dismukes WE, Meade RH III, Moses JM: A new therapeutic approach to Candida infection. Arch Intern Med 130:241–245, 1972.

    PubMed  CAS  Google Scholar 

  164. Siegel MJ, Shackelford GD, McAlister WH: Posterior mediastinal masses secondary to lymphadenitis from esophagitis. Radiology 140:377–379, 1981.

    PubMed  CAS  Google Scholar 

  165. Singer C, Armstrong D, Rosen PP, Walzer PD, Yu B: Diffuse pulmonary infiltrates in immunosuppressed patients. Prospective study of 80 cases. Am J Med 66:110–120, 1979.

    PubMed  CAS  Google Scholar 

  166. Tenholder MF, Hooper RG: Pulmonary infiltrates in leukemia. Chest 78:468–473, 1980.

    PubMed  CAS  Google Scholar 

  167. Jaffe JP, Maki DG: Lung biopsy in immunocompromised patients: one institution’s experience and an approach to management of pulmonary disease in the compromised host. Cancer 48:1144–1153, 1981.

    PubMed  CAS  Google Scholar 

  168. Greenman RL, Goodall PT, King D: Lung biopsy in immunocompromised hosts. Am J Med 59:488–496, 1975.

    PubMed  CAS  Google Scholar 

  169. Wells RJ, Weetman RM, Ballantine TV, Grosfeld JL, Baehner RL: Pulmonary leukemia in children presenting as diffuse interstitial pneumonia. J pedriatr 96:262–264, 1980.

    CAS  Google Scholar 

  170. Weiss RB, Muggia FM: Cytotoxic drug-induced pulmonary disease: Update 1980. Am J Med 68:259–266, 1980.

    PubMed  CAS  Google Scholar 

  171. Pennington JE, Feldman NT: Pulmonary infiltrates and fever in patients with hematologic malignancy. Assessment of transbronchial biopsy. Am J Med 62:581–587, 1977.

    PubMed  CAS  Google Scholar 

  172. Burt ME, Flye MW, Webber BL, Wesley RA: Prospective evaluation of aspiration needle, cutting needle, transbronchial and open lung biopsy in patients with pulmonary infiltrates. Ann Thorac Surg 32:146–153, 1981.

    PubMed  CAS  Google Scholar 

  173. Chang H Y, Rodriguez V, Narboni G, et al..: Causes of death in adults with acute leukemia. Medicine 55:259–268, 1976.

    PubMed  CAS  Google Scholar 

  174. Valdivieso M, Gil-Extremera B, Zornoza J, Rodriguez V, Bodey GP: Gramnegative bacil-lary pneumonia in the compromised host. Medicine 56:241–254, 1977.

    PubMed  CAS  Google Scholar 

  175. Commers JR, Robichaud KJ, Pizzo PA: New pulmonary infiltrates in granulocytopenic cancer patients being treated with antibiotics. J Infect Dis (in press).

    Google Scholar 

  176. Pennington JE: Successful treatment of Aspergillus pneumonia in hematologic neoplasia. N Engl J Med 295:426–427, 1976.

    PubMed  CAS  Google Scholar 

  177. Aisner J, Schimpff SC, Wiernik PH: Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 86:539–543, 1977.

    PubMed  CAS  Google Scholar 

  178. Young LS: Trimethoprim-sulfamethowxazole in the treatment of adults with pneumonia due to Pneumocystis carinii. Rev Infect Dis 4:608–613, 1982.

    PubMed  CAS  Google Scholar 

  179. Kirby BD, Snyder KM, Meyer RD, Finegold SM: Legionnaires’ disease: report of 65 nosocomially acquired cases and review of the literature. Medicine 59:188–205, 1980.

    PubMed  CAS  Google Scholar 

  180. Jendrzejewski JW, Jones SR, Newcombe RL, Gilbert DN: Nontraumatic clostridial myonecrosis. Am J Med 65:542–546, 1978.

    PubMed  CAS  Google Scholar 

  181. Wynne JW, Armstrong D: Clostridial septicemia. Cancer 29:215–221, 1972.

    PubMed  CAS  Google Scholar 

  182. Andes WA: Spontaneous clostridial sepsis and sudden death. South Med J 75:378–379, 1982.

    PubMed  CAS  Google Scholar 

  183. Alpern RJ, Dowell VR: Clostridum septicum infections and malignancy. JAMA 209:385–388, 1969.

    PubMed  CAS  Google Scholar 

  184. Alpern RJ, Dowell VR: Non-histotoxic clostridial bacteremia. Am J Clin Pathol 55:717–722, 1971.

    PubMed  CAS  Google Scholar 

  185. Silva J, Batts DH, Fekety R, et al.: Treatment of Clostridium difficle colitis and diarrhea with vancomycin. Am J Med 71:815–821, 1981.

    PubMed  Google Scholar 

  186. Cudmore MA, Silva J, Fekety R, et al.: Clostridium difficle colitis associated with cancer chemotherapy. Arch Intern Med 142:333–335, 1982.

    PubMed  CAS  Google Scholar 

  187. Kim KH, Fekety R, Batts DH: Isolation of Clostridium difficle from environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143:42–50, 1981.

    PubMed  CAS  Google Scholar 

  188. Rivera E, Maldonado N, Velez-Garcia E, et al.: Hyperinfection syndrome with Strongy-loides stercoralis. Ann Intern Med 72:199–204, 1970.

    PubMed  CAS  Google Scholar 

  189. Purtilo DT, Meyers WM, Connor DH: Fatal strongyloidiasis in immunosuppressed patients. Am J Med 56:488–493, 1974.

    PubMed  CAS  Google Scholar 

  190. Schimpff SC, Wiernik PH, Block JB: Rectal abscesses in cancer patients. Lancet ii: 844–847, 1972.

    Google Scholar 

  191. Barnes SG, Sattler FR, Ballard JO: Improved survival after drainage of perirectal infections in patients with acute leukemia. 22nd Interscien Confern Antimicrob AgChemother: 67, 1982.

    Google Scholar 

  192. McGill TJ, Simpson G, Healy GB: Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope 90:748–754, 1980.

    PubMed  CAS  Google Scholar 

  193. Meyer RD, Rosen P, Armstrong D: Physomycosis complicating leukemia and lymphoma. Ann Intern Med 77:871–879, 1972.

    PubMed  CAS  Google Scholar 

  194. Viollier A-F (personal communication).

    Google Scholar 

  195. Mahoney DH, Steuber CP, Starling KA, et al.: An outbreak of aspergillosis in children with acute leukemia. J Pediatr 95:70–71, 1979.

    PubMed  Google Scholar 

  196. Berkow RL, Weisman SJ, Provisor AJ, et al.: Invasive aspergillosis of paranasal tissues in children with malignancies. J Pediatr 103:49–53, 1983.

    PubMed  CAS  Google Scholar 

  197. Higby DJ, Yaters J, Henderson ES, Holland JF: Filtration leukapheresis for granulocyte transfusion therapy. N Engl J Med 292:761–766, 1975.

    PubMed  CAS  Google Scholar 

  198. Alavi JB, Root RK, Djerassi I, et al.: Leukocyte transfusions in acute leukemia. New Engl J Med 296:706–711, 1977.

    PubMed  CAS  Google Scholar 

  199. Volger WR, Winton EF: The efficacy of granulocyte transfusions in neutropenic patients. Am J Med 63:548–555, 1977.

    Google Scholar 

  200. Herzig R, Herzig G, Graw RG, et al.: Efficacy of granulocyte transfusion therapy for gram-negative sepsis: a prospective randomized controlled study. N Engl J Med 296:701–705, 1977.

    PubMed  CAS  Google Scholar 

  201. Winston DJ, Ho WG, Gale RP: Therapeutic granulocyte transfusions for documented infections. Ann Intern Med 97:509–515, 1982.

    PubMed  CAS  Google Scholar 

  202. Young LS: The role of granulocyte transfusions in treating and preventing infection. Cancer Treat Rep 67:109–111, 1983.

    PubMed  CAS  Google Scholar 

  203. Schiffer CA: Granulocyte transfusion therapy. Cancer Treat rep 67:113–119, 1983.

    PubMed  CAS  Google Scholar 

  204. Buescher ES, Holland PV, Gallin JI: Radiation induced defective oxygen metabolism in leukocytes prepared for transfusion as assessed by nitroblue tetrazolium reduction. Clin Res 31:309A, 1983.

    Google Scholar 

  205. Schiffer CA, Aisner J, Daly PA, et al.: Alloimmunization following prophylactic granulocyte transfusion. Blood 54:766–774, 1979.

    PubMed  CAS  Google Scholar 

  206. Straus RG, Connett JE, Gale RP, et al.: A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 305:597–603, 1981.

    Google Scholar 

  207. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 304:1185–1189, 1981.

    PubMed  CAS  Google Scholar 

  208. Dana BW, Durie BGM, White RF, et al.: Concomitant adminstration of granulocyte transfusions and amphotericin B in neutropenic patients: Absence of significant pulmonary toxicity. Blood 57:90–94, 1981.

    PubMed  CAS  Google Scholar 

  209. Boxer LA, Ingraham LM, Allen J, et al.: Amphotericin-B promotes leukocyte aggregation of nylon-wool-fiber-treated polymorphonuclear leukocytes. Blood 58:518–522, 1981.

    PubMed  CAS  Google Scholar 

  210. Roth JA, Siegel SE, Levine AS, Berard CW: Fatal recurrent toxoplasmosis in a patient initially infected via a leukocyte transfusion. Am J Clin Pathol 56:601–605, 1971.

    PubMed  CAS  Google Scholar 

  211. Twomey JJ: Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med 132:562–565, 1973.

    PubMed  CAS  Google Scholar 

  212. Peter G, Pizzo P, Robichaud K, et al.: Possible protective effect of circulating antibiodies to the shared core glycolipid of enterobacteriaceae in children with malignancy. Pediatr Res 13:466, 1979.

    Google Scholar 

  213. Braude AI, Douglas H, Davis CE: Treatment and prevention of intravascular coagulation with antiserum to endotoxin. J Infect Dis 128(Suppl):s157–s164, 1973.

    Google Scholar 

  214. Ziegler EJ, McCutchan JA, Fierer S, et al.: Successful treatment of gram-negative bacteremia and shock with human antiserum to a UDP-GAL epimerase-deficient mutant Escherichia coli. N Engl J Med 307:1225–1230, 1982.

    PubMed  CAS  Google Scholar 

  215. Chan HSL, Saunders EF, Freedman MH: Modulation of human hematopoiesis by prostaglandins and lithium. J Lab Clin Med 95:125–132, 1980.

    PubMed  CAS  Google Scholar 

  216. Shopsin B, Friedman R, Gershon S: Lithium and leukocytosis. Clin Pharmacol Ther 12:923–928, 1971.

    PubMed  CAS  Google Scholar 

  217. Stein RS, Vogler WR, Lefante J: Faillure of lithium to limit neutropenia during induction therapy of acute myelogenous leukemia. Proc Am Assoc Can Res/Am Soc Clin Oncol 22:423, 1981.

    Google Scholar 

  218. Kohsaki M, Noguchi K, Araki K, et al.: In vivo stimulation of murine granulopoiesis by human urinary extract from patients with aplastic anamia. Proc Natl Acad Sci 80:3802–3806, 1983.

    PubMed  CAS  Google Scholar 

  219. Gauwerky CE, Golde DW: Lithium enhances growth of human leukemia cells in vitro. Brit J Haematol 51:431–438, 1982.

    CAS  Google Scholar 

  220. Albert RK, Condie F: Handwashing patterns in medical intensive care units. N Engl J Med 304:1465–1466, 1981.

    PubMed  CAS  Google Scholar 

  221. Nauseff WM, Maki DG: A study of value of simple protective isolation in patients with granulocytopenia. N Engl J Med 304:448–453, 1981.

    Google Scholar 

  222. Yates JW, Holland JF: A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer 32:1490–1498, 1973.

    PubMed  CAS  Google Scholar 

  223. Levine AS, Siegal SE, Schreiber AD, et al.: Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 288:477–483, 1973.

    PubMed  CAS  Google Scholar 

  224. Bodey GP, Rodriguez V: Infections in cancer patients on a protected environment, prophylactic antibiotic program. Am J Med 59:497–504, 1975.

    PubMed  CAS  Google Scholar 

  225. Schimpff SC, Greene WH, Young VA, et al.: Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 82:351–358, 1975.

    PubMed  CAS  Google Scholar 

  226. Rodriguez V, Bodey GP, Friereich EJ, et al.: Randomized trial of protected environment prophylactic antibiotics in 145 adults with acute leukemia. Medicine 57:253–266, 1978.

    PubMed  CAS  Google Scholar 

  227. Lohner D, Debusscher L, Prevost JM, Klastersky J: Comparative randomized study of protected environments plus oral antibiotics versus oral antibiotics alone in neutropenic patients. Cancer Treat Rep 63:363–368, 1979.

    PubMed  CAS  Google Scholar 

  228. Cotton DJ, Pizzo PA: Prevention of infection in patients with hematologic malignancy. In: Neoplastic Diseases of the Blood and Blood-Forming Organs, Wiernik PH, Canellos G, Kyle RA, Schiffer CA (eds), New York, Churchill Livingstone Inc., 1985.

    Google Scholar 

  229. Pizzo PA: Do results justify the expense of protected environments? in: Controversies in Oncology. Wiernik PH (ed), New York, John Wiley and Sons, 1981, p267.

    Google Scholar 

  230. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D: Mitigation of secondary disease of allogenic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 52:401–404, 1974.

    PubMed  Google Scholar 

  231. Storb R, Prentice RL, Buckner CD, et al.: Graft-versus-host-disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: beneficial effects of a protective environment. N Engl J Med 308:302–307, 1983.

    PubMed  CAS  Google Scholar 

  232. Levi JA, Vincent PC, Jennis F, et al.: Prophylactic oral antibiotics in the managment of acute leukaemia. Med J Aust 1:1025–1029, 1973.

    PubMed  CAS  Google Scholar 

  233. Dietrich M, Gaus W, Vossen J, et al.: Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. Infection 5:107–114, 1977.

    PubMed  CAS  Google Scholar 

  234. Reiter B, Gee T, Young L, et al.: Use of oral antimicrobials during remission induction in adult patients with acute nonlymphoblastic leukemias. Clin Res 21:652, 1973.

    Google Scholar 

  235. Stoning RA, McElwain TJ, Jameson B, Wiltshaw E: Oral nonabsorbed antibiotics prevent infection in acute non-lymphoblastic leukemia. Lancet ii:837–840, 1977.

    Google Scholar 

  236. Hahn EM, Schimpff SC, Fortner CL, et al.: Infection in acute leukemia patients receiving nonabsorbable antibiotics. Antimicrob Ag Chemother 13:958–964, 1978.

    CAS  Google Scholar 

  237. King K: Prophyactic non-absorbable antibiotics in leukemia patients. J Hyg (Camb) 85:141–151, 1980.

    CAS  Google Scholar 

  238. Pizzo PA: Protected isolation of pediatric cancer patients receiving intensive chemotherapy: influence of autologous bone marrow rescue on infectious complications. 21st Inter-scien Confern Antimicrob Ag Chemother: 799, 1981.

    Google Scholar 

  239. van der Waaij D, Berghuis-de Vries JM, Lekkerker-van der Wees JEC, et al.: Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (London) 69:405–411, 1971.

    Google Scholar 

  240. Guiot MFL, van der Meer JWM, van Furth R: Infection prevention by partial antitiotic decontamination. 11th Intern Confern Chemother/19th Interscien Confern Antimicrob Ag Chemother: 61, 1979.

    Google Scholar 

  241. Guiot HFL, van der Meer JWM, van Furth R: Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanism by selective elimination of potentially pathogenic bacteria. J Infect Dis 143:644–654, 1981.

    PubMed  CAS  Google Scholar 

  242. Sleijfer DT, Muldor NH, de Vries-Hospers HG, et al.: Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Europ J Cancer 16:859–869, 1980.

    CAS  Google Scholar 

  243. Wade J, Schimpff SC, Hargadon MT et al.: A comparison of trimethoprimsulfamethoxa-zole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 304:1057–1062, 1981.

    PubMed  CAS  Google Scholar 

  244. Wade J, deJongh C, Newman K, et al.: A comparison of trimethoprim/sulfamethoxazole to nalidixic acid: Selective decontamination as infection prophylaxis during granulocytopenia. 21st Interscien Confern Antimicrob Ag Chemother: 796, 1981.

    Google Scholar 

  245. Hughes WT, Kuhn S, Chaudhury S, et al.: Successful chemoprophylaxis for Pneumocystis carinii pneumonotis. N Engl J Med 297:1419–1426, 1977.

    PubMed  CAS  Google Scholar 

  246. Gurwith MJ, Brunton JL, Lank BA, et al.: A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66:248–256, 1979.

    PubMed  CAS  Google Scholar 

  247. Enno A, Darrell J, Hows J, et al.: Co-trimoxazole for prevention of infection in acute non-lymphoblastic leukemia. Lancet ii:395–397, 1978.

    Google Scholar 

  248. Weiser B, Lange M, Fialk MA, et al.: Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. Ann Intern Med 95:436–438, 1981.

    PubMed  CAS  Google Scholar 

  249. Dekker AW, Rozenberg-Arska M, Sixma JJ, et al.: Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia. Ann Intern Med 95:555–559, 1981.

    PubMed  CAS  Google Scholar 

  250. Zinner S, Gaya H, Glauser M, et al.: Cotrimoxazole and reduction of risk of infection in neutropenic patients. A progress report for the EORTIC Antimicrobial Therapy Project Group. 21st Interscien Confern Antimicrob Ag Chemother: 795, 1981.

    Google Scholar 

  251. Kauffman CA, Liepman MK, Bergman AG, Mioduszewski J: Trimethoprim-sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora. Am J Med 74:599–607, 1983.

    PubMed  CAS  Google Scholar 

  252. Gualtieri RJ, Donowitz GR, Kaiser CE, et al.: Double-blind randomized study of prophylactic trimethoprim-sulfamethoxazole in granulocytopenic patients with hematologic malignancies. Am J Med 74:934–940, 1983.

    PubMed  CAS  Google Scholar 

  253. Pizzo PA, Robichaud KJ, Edwards BK, et al.: Oral antibiotic prophylaxis in cancer patients: a double blind randomized placebo controlled trial. J Pediatr 102:125–133, 1983.

    PubMed  CAS  Google Scholar 

  254. Murray BE, Rensimer ER, DuPont HL: Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethorim-sulfa-methoxazole, N Engl J Med 306:130–135, 1982.

    PubMed  CAS  Google Scholar 

  255. Degregorio M, Lee W, Ries C: Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 50:2780–2784, 1983.

    Google Scholar 

  256. Williams C, Whitehouse JMA, Lister TA, Wrigley PFM: Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia. Med Pediatr Oncol 3:275–280, 1977.

    PubMed  CAS  Google Scholar 

  257. Meunier-Carpentier F, Cruciani M, Klastersky J: Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. Eur J Can (in press).

    Google Scholar 

  258. Whitley RJ, Soong SJ, Dolin R, et al.: Early vidarabine therapy to control the complications of herpes zoster in immunocompromised patients. N Engl J Med 307:971–975, 1982.

    PubMed  CAS  Google Scholar 

  259. Balfour HH, Bean B, Laskin OL, et al.: Acylovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 308:1448–1453, 1983.

    PubMed  Google Scholar 

  260. Crumpacker CS, Schnipper LE, Marlowe SI, et al.: Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med 306:343–346, 1982.

    PubMed  CAS  Google Scholar 

  261. Siber GR, Weitzman SA, Aisenberg AC, et al.: Impaired antibody response to pneumonoccal vaccine after treatment for Hodgkin’s disease. N Engl J Med 299:442–448, 1978.

    PubMed  CAS  Google Scholar 

  262. Minor DR, Schiffman G, Mcintosh LS, et al.: Response of patients with Hodgkin’s disease to pneumococcal vaccine. Ann Intern Med 90:887–892, 1979.

    PubMed  CAS  Google Scholar 

  263. Pennington JF, Reynolds HY, Wood RE, et al.: Use of Pseudomonas aeruginosa vaccine in patients with acute leukemia and cystic fibrosis. Am J Med 58:629–636, 1975.

    PubMed  CAS  Google Scholar 

  264. Lange B, Shapario SA, Waldman MTG, et al.: Antibody response to influenza immunization of children with acute lymphoblastic leukemia. J Infext Dis 140:402–406, 1979.

    CAS  Google Scholar 

  265. Schafer AI, Churchill WH, Ames P, et al.: The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 43:25–30, 1979.

    PubMed  CAS  Google Scholar 

  266. Brunell PA, Shehab Z, Geiser C, Waugh JE: Administration of live varicella vaccine in children with leukemia. Lancet ii: 1069–1072, 1982.

    Google Scholar 

  267. Zaia JA, Levin MJ, Preblud SR, et al.: Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children with household exposure to varicella. J Infect Dis 147:737–743, 1983.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. John W. Hiemenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip A. Pizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Medical Oncology, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA

    Clara D. Bloomfield

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Hiemenz, J.W., Pizzo, P.A. (1985). New Developments in the Etiology, Diagnosis, Treatment and Prevention of Infectious Complications in Patients with Leukemia. In: Bloomfield, C.D. (eds) Chronic and Acute Leukemias in Adults. Cancer Treatment and Research, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2581-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2581-9_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9619-5

  • Online ISBN: 978-1-4613-2581-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation